Home / Psoriasis / Some data support botulinum toxin for psoriasis and rosacea

Some data support botulinum toxin for psoriasis and rosacea

– Botulinum toxin may have a place in treating psoriasis and rosacea.

There is not a huge body of literature supporting the use of neuromodulators for these conditions, but a smattering of case reports have shown positive results and some clinicians are exploring their off label use, Erin Gilbert, MD, said at the annual meeting of the American Academy of Dermatology.

“I do believe that there is significant promise here and certainly enough evidence to warrant conducting well-designed randomized, controlled trials for these conditions,” said Dr. Gilbert, a dermatologist in Brooklyn, NY. “It is of utmost importance that we pair clinical outcome measures with methods that will help us better understand the mechanism of action of neuromodulators in human skin, such as skin biopsy.”

Full Article

About Dr. J. Kim

Dr Kim developed (and is continuing to develop) dermatology research news as we way from dermatologists to stay on top of the latest advances in the field of dermatology.

Check Also

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-1)

Study Description Go to  Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Brief Summary: The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis. Condition or disease Intervention/treatment Phase Psoriasis Drug: Mirikizumab Drug: Placebo Phase 3 …

Leave a Reply

Your email address will not be published. Required fields are marked *